Paper42492499
Feasibility, Acceptability, and Test Performance of Point-of-Care Nucleic Acid Tests for HIV Testing and Viral Load Monitoring in the United States: Prospective Longitudinal Mixed-Methods Study.
Niemann LA and 11 others. JMIR Res Protoc, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Feasibility, Acceptability, and Test Performance of Point-of-Care Nucleic Acid Tests for HIV Testing and Viral Load Monitoring in the United States: Prospective Longitudinal Mixed-Methods Study. Papers, record 42492499. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42492499
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Feasibility, Acceptability, and Test Performance of Point-of-Care Nucleic Acid Tests for HIV Testing and Viral Load Monitoring in the United States: Prospective Longitudinal Mixed-Methods Study.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Viral Load | Major topic |
| HIV Infections | Major topic |
| HIV Testing | Major topic |
| Point-of-Care Testing | Major topic |
| Patient Acceptance of Health Care | Major topic |
| Point-of-Care Systems | Major topic |
| Humans | |
| Prospective Studies | |
| Feasibility Studies | |
| Female | |
| Longitudinal Studies | |
| Male | |
| Adult | |
| United States | |
| Washington | |
| Middle Aged | |
| Rapid Diagnostic Tests | |
| HIV-1 |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 PS005196 | NCHHSTP CDC HHS | United States | U01PS005196 | PubMed | NIH RePORTER |
| UL1 TR002319 | NCATS NIH HHS | United States | UL1TR002319 | PubMed | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04880200 | Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests | Derived from the trial | Yes |
Source ClinicalTrials.gov
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11029005 | Immune control of HIV-1 after early treatment of acute infection. | Nature | 2000 | https://conductscience.org/library/papers/11029005 | PubMed |
| 2 | 32105625 | Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial. | Lancet HIV | 2020 | https://conductscience.org/library/papers/32105625 | PubMed |
| 3 | 34974473 | Evaluation of SAMBA II: A Qualitative and Semiquantitative HIV Point-of-Care Nucleic Acid Test. | J Acquir Immune Defic Syndr | 2022 | https://conductscience.org/library/papers/34974473 | PubMed |
| 4 | 16052089 | Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. | AIDS | 2005 | https://conductscience.org/library/papers/16052089 | PubMed |
| 5 | 10950796 | Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection. | J Infect Dis | 2000 | https://conductscience.org/library/papers/10950796 | PubMed |
| 6 | 11698702 | Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. | AIDS | 2001 | https://conductscience.org/library/papers/11698702 | PubMed |
| 7 | 36528677 | "After viral load testing, I get my results so I get to know which path my life is taking me": qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies. | BMC Health Serv Res | 2022 | https://conductscience.org/library/papers/36528677 | PubMed |
| 8 | 31441242 | Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi. | J Int AIDS Soc | 2019 | https://conductscience.org/library/papers/31441242 | PubMed |
| 9 | 33239012 | Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa. | BMC Health Serv Res | 2020 | https://conductscience.org/library/papers/33239012 | PubMed |
| 10 | 29630852 | The Max Clinic: Medical Care Designed to Engage the Hardest-to-Reach Persons Living with HIV in Seattle and King County, Washington. | AIDS Patient Care STDS | 2018 | https://conductscience.org/library/papers/29630852 | PubMed |
| 11 | 15809897 | Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. | J Infect Dis | 2005 | https://conductscience.org/library/papers/15809897 | PubMed |
| 12 | 12270653 | Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV. | J Virol Methods | 2002 | https://conductscience.org/library/papers/12270653 | PubMed |
| 13 | 17638724 | Negative rapid HIV antibody testing during early HIV infection. | Ann Intern Med | 2007 | https://conductscience.org/library/papers/17638724 | PubMed |
| 14 | 41128485 | The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of HIV Nucleic Acid Assays in the United States. | Clin Infect Dis | 2026 | https://conductscience.org/library/papers/41128485 | PubMed |
| 15 | 29280768 | HIV Pre-exposure Prophylaxis Prescribing Through Telehealth. | J Acquir Immune Defic Syndr | 2018 | https://conductscience.org/library/papers/29280768 | PubMed |
| 16 | 10608758 | Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection. | J Infect Dis | 2000 | https://conductscience.org/library/papers/10608758 | PubMed |
| 17 | 26774543 | Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM. | J Clin Virol | 2016 | https://conductscience.org/library/papers/26774543 | PubMed |
| 18 | 35305378 | Performance assessment of the new Xpert® HIV-1 viral load XC assay for quantification of HIV-1 viral loads. | J Clin Virol | 2022 | https://conductscience.org/library/papers/35305378 | PubMed |
| 19 | 31246963 | Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care. | PLoS One | 2019 | https://conductscience.org/library/papers/31246963 | PubMed |
| 20 | 30278030 | Chlamydia, Gonorrhea, and Human Immunodeficiency Virus Infection Among Transgender Women and Transgender Men Attending Clinics that Provide Sexually Transmitted Disease Services in Six US Cities: Results From the Sexually Transmitted Disease Surveillance Network. | Sex Transm Dis | 2019 | https://conductscience.org/library/papers/30278030 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42492499
GET https://conductscience.org/api/papers/v1/42492499/references?page=2